Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes

Journal of the American Pharmacists Association

Volumn 53, Issue 4, 2013, Pages 427-431

  Rettig, Stephen M ^a,b   Wood, Yelena ^c,d   Hirsch, Jan D ^a,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Neurosciences Critical Care Units   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Premier Physician Medical Group   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Medication regimen complexity; Medication regimen complexity index; Medication therapy management

Indexed keywords

ADULT; AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HUMAN; HYPERTENSION; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MEDICATION REGIMEN COMPLEXITY; MEDICATION REGIMEN COMPLEXITY INDEX; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; RETROSPECTIVE STUDY; SCORING SYSTEM;

EID: 84890509108     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2013.13003     Document Type: Article

References (18)

1. Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171(9):814-22.
2. Corsonello A, Pedone C, Lattanzio F, et al. Regimen complexity and medication nonadherence in elderly patients. Ther Clin Risk Manag. 2009;5(1):209-16.
3. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213-24.
4. Neri L, Martini A, Andreucci VE, et al. Regimen complexity and prescription adherence in dialysis patients. Am J Nephrol. 2011;34(1):71-6.
5. Dickson M, Plauschinat CA. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy. Am J Cardiovasc Drugs. 2008;8(1):45-50.
6. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150(9):1881-4.
7. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 2002;36(10):1532-9.
8. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997;20(10):1512-7.
9. Pan F, Chernew ME, Fendrick AM. Impact of fixed-dose combination drugs on adherence to prescription medications. J Gen Intern Med. 2008;23(5):611-4.
10. George J, Phun YT, Bailey MJ, et al. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369-76.
11. Pollack M, Chastek B, Williams SA, Moran J. Impact of treatment complexity on adherence and glycemic control: an analysis of oral antidiabetic agents. J Clin Outcomes Manag. 2010;17(6):257-65.
12. Correr CJ, Melchiors AC, Fernandez-Llimos F, Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011;33(2):273-80.
13. Oosthuizen F, Dhoodhat E, Kazi S, et al. Assessing the complexity of medicine regimens: a pilot study. African Journal of Pharmacy and Pharmacology. 2011;5(16):1863-6.
14. Moczygemba LR, Barner JC, Gabrillo ER. Outcomes of a Medicare Part D telephone medication therapy management program. J Am Pharm Assoc. 2012;52:e144-52.
15. Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234-40.
16. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-9.
17. National Heart, Lung, and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. www.nhlbi.nih.gov/guidelines/hypertension/express.pdf. Accessed March 4, 2012.
18. Rosenzweig JL, Weinger K, Poirier-Solomon L, Rushton M. Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus. Am J Manag Care. 2002;8(11):950-8.